Notably, TIGIT and CD39 were shown to be upregulated in PB NK cells from patients with acute myeloid leukemia and in esophageal squamous cell carcinoma, respectively (65, 66), suggesting specific IC regulation mechanisms that depend on the tumor type. Here, TIGIT is linked to neoplasm.